Login to Your Account



Tufts CSDD: Cost to develop new drug balloons to $2.6B

By Marie Powers
Staff Writer

Tuesday, November 18, 2014

Drugmakers that complain about the growing cost to bring new molecular entities to market aren't exaggerating, according to a study released Tuesday by the Tufts Center for the Study of Drug Development (CSDD).

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription